Last Updated on December 24, 2023 by The Health Master
New Delhi: Zydus Lifesciences said it has received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-release tablets used for treatment of moderate to severe acne.
The approval granted by the US Food and Drug Administration (USFDA) is for Minocycline Hydrochloride extended-release tablets of strengths 55 mg, 65 mg, and 115 mg, Zydus Lifesciences said in a regulatory filing.
The tablet is used for treatment of moderate to severe acne in people aged 12 years and above.
The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad, the company said.
USFDA gives final nod for Varenicline Tablets
USFDA gives approval for Levetiracetam Tablets
USFDA gives approval for Metoprolol Succinate ER Tablets
USFDA gives approval for Cisatracurium Besylate injection
German pharma major Bayer stops business in Pakistan: Report
Importance of Quality and Regulations in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
PCI: Pharmacy is an independent profession, not paramedical course
209 Pharma companies under Govt lens over violations
CDSCO Committee to probe ‘faulty’ optical lens supplied by Swiss-American firm
DCGI gives EUA for this booster Vaccine from Gennova
Strict actions imposed on Pharma Wholesalers for breaching license conditions Assam
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
